Literature DB >> 19070499

Antibacterial 5'-O-(N-dipeptidyl)-sulfamoyladenosines.

P Van de Vijver1, G H M Vondenhoff, S Denivelle, J Rozenski, J Verhaegen, A Van Aerschot, P Herdewijn.   

Abstract

The aminoacyl-tRNA synthetase (aaRS) class of enzymes is a validated target for antimicrobial development. Aminoacyl analogues of 5'-O-(N-L-aminoacyl)-sulfamoyladenosines are known to be potent inhibitors of aaRS, but whole cell antibacterial activity of these compounds is very limited, and poor penetration into bacteria has been proposed as the main reason for this. Aiming to find derivatives that better penetrate bacteria, we developed a simple and short method to prepare dipeptidyl-derivatives of 5'-O-(N-L-aminoacyl)-sulfamoyladenosines, and used this method to prepare 18 5'-O-(N-dipeptidyl)-sulfamoyladenosines. The antibacterial activity of these derivatives and a number of reference compounds against S. aureus, E. faecalis and E. coli was determined. Several of the new derivatives showed improved antibacterial activity and an altered spectrum of antibacterial activity.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 19070499     DOI: 10.1016/j.bmc.2008.11.054

Source DB:  PubMed          Journal:  Bioorg Med Chem        ISSN: 0968-0896            Impact factor:   3.641


  5 in total

1.  Parallel synthesis of a series of non-functional ATP/NAD analogs with activity against trypanosomatid parasites.

Authors:  Andreas Link; Philipp Heidler; Marcel Kaiser; Reto Brun
Journal:  Mol Divers       Date:  2009-05-30       Impact factor: 2.943

Review 2.  Recent development of leucyl-tRNA synthetase inhibitors as antimicrobial agents.

Authors:  Panpan Zhang; Shutao Ma
Journal:  Medchemcomm       Date:  2019-05-27       Impact factor: 3.597

3.  N-Leucinyl Benzenesulfonamides as Structurally Simplified Leucyl-tRNA Synthetase Inhibitors.

Authors:  Michael H Charlton; Rihards Aleksis; Adélaïde Saint-Leger; Arya Gupta; Einars Loza; Lluís Ribas de Pouplana; Ilze Kaula; Daina Gustina; Marina Madre; Daina Lola; Kristaps Jaudzems; Grace Edmund; Christopher P Randall; Louise Kime; Alex J O'Neill; Wil Goessens; Aigars Jirgensons; Paul W Finn
Journal:  ACS Med Chem Lett       Date:  2018-01-18       Impact factor: 4.345

Review 4.  Targeting adenylate-forming enzymes with designed sulfonyladenosine inhibitors.

Authors:  Michaelyn C Lux; Lisa C Standke; Derek S Tan
Journal:  J Antibiot (Tokyo)       Date:  2019-04-15       Impact factor: 2.649

5.  N-alkylated aminoacyl sulfamoyladenosines as potential inhibitors of aminoacylation reactions and microcin C analogues containing D-amino acids.

Authors:  Gaston H Vondenhoff; Ksenia Pugach; Bharat Gadakh; Laurence Carlier; Jef Rozenski; Mathy Froeyen; Konstantin Severinov; Arthur Van Aerschot
Journal:  PLoS One       Date:  2013-11-04       Impact factor: 3.240

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.